home / stock / grts / grts news


GRTS News and Press, Gritstone Oncology Inc. From 01/19/21

Stock Information

Company Name: Gritstone Oncology Inc.
Stock Symbol: GRTS
Market: NASDAQ
Website: gritstonebio.com

Menu

GRTS GRTS Quote GRTS Short GRTS News GRTS Articles GRTS Message Board
Get GRTS Alerts

News, Short Squeeze, Breakout and More Instantly...

GRTS - Why Gritstone Oncology Is Bolting Higher Today

Shares of the clinical-stage biotech Gritstone Oncology (NASDAQ: GRTS) rose by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is heating up today in response to an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to initia...

GRTS - GME, LAC, AMC and COHR among premarket gainers

Tenax Therapeutics, Inc. (TENX) +70% after announcing acquisition of PH Precision Med.Aclaris Therapeutics (ACRS) +66% on positive data from mid-stage rheumatoid arthritis.Minerva Neurosciences (NERV) +42% on announcing sale of Seltorexant Royalty for up to $155M.China Natural ...

GRTS - Gritstone Oncology (GRTS) on go with Phase 1 trial of COVID-19 vaccine, shares up 34%

Gritstone Oncology (GRTS) jumps 34% premarket in reaction to advancing development of a second generation vaccine against SARS-CoV-2, with potential for both prolonged protection and potency against Spike mutants.The company and the National Institute of Allergy and Infectious Disea...

GRTS - Gritstone Advances Second Generation COVID-19 Vaccine "CORAL" Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2

--Gritstone to Host Conference Call Today at 8:00 a.m. ET-- EMERYVILLE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, today an...

GRTS - Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, presiden...

GRTS - SYN, TRXC, JAGX and BNGO among midday movers

Gainers: Synthetic Biologics (SYN) +141%.Helius Medical Technologies (HSDT) +91%.The Peck Company (PECK) +79%.Atomera (ATOM) +50%.Check-Cap (CHEK) +49%.Naked Brand Group (NAKD) +42%.The9 (NCTY) +37%.Gritstone Oncology (GRTS) +36%.Boston Private Financial (BPFH) +31%.Jaguar Heal...

GRTS - Best Penny Stocks to Buy This Week? 4 Biotech Stocks To Watch

Are These Penny Stocks on Your Watch List Right Now? With the new year in full swing, investors are recharged and ready to find opportunities. When first searching for the “best penny stocks ” or at least the “best” for right now, there are a few things t...

GRTS - CHU, CHL, FUBO and SKLZ among premarket gainers

Aileron Therapeutics (ALRN) +73%.Broadway Financial Corporation (BYFC) +55% after regulatory approvals for merger with CFBanc Corporation.Atlantic American Corporation (AAME) +43%.Marker Therapeutics (MRKR) +30% after FDA lifted the partial clinical hold on it's Phase 2 trial.Cyclo ...

GRTS - AAME, AIH, GDS and VRAY among after-hours movers

Gainers: [[AAME]] +53.3%. [[BPFH]] +27.8%. [[AIH]] +11.4%. [[ASLN]] +11.2%. [[GRTS]] +10.1%.Losers: [[VRAY]] -11.1%. [[GDS]] -8.4%. [[PBYI]] -5.5%. [[ACY]] -5.4%. [[GBIO]] -5.3%. For further details see: AAME, AIH, GDS and VRAY among after-hours movers

GRTS - Gritstone Oncology +9.3% AH, EcoR1 discloses ~10% stake in company

EcoR1 Capital disclosed a 9.99% stake in Gritstone Oncology (GRTS), which represents over 4.87M shares.The filing does not allow for activism.Shares +9.3% during after hours. For further details see: Gritstone Oncology +9.3% AH, EcoR1 discloses ~10% stake in company

Previous 10 Next 10